Condition
Inappropriate Sinus Tachycardia
Total Trials
8
Recruiting
1
Active
2
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
Termination Rate
12.5%
1 terminated out of 8 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
13%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
P 3 (1)
Trial Status
Completed2
Unknown2
Recruiting1
Withdrawn1
Terminated1
Active Not Recruiting1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
Showing 8 of 8 trials
NCT05280093Not ApplicableActive Not RecruitingPrimary
HEAL-IST IDE Trial
NCT05107635RecruitingPrimary
Inappropriate Sinus Tachycardia Registry
NCT07138131Not ApplicableCompleted
Impact of Omega 3 in Treatment of Inappropriate Sinus Tachycardia
NCT00584649Not ApplicableTerminatedPrimary
Ablation of Inappropriate Sinus Tachycardia
NCT02018497Unknown
Essential Hypotension and Allostasis Registry
NCT03317249UnknownPrimary
Pregnancy Related Inappropriate Sinus Tachycardia
NCT01657136Phase 3CompletedPrimary
Ivabradine Versus Beta-blockers in the Treatment of Inappropriate Sinus Tachycardia
NCT01695538Not ApplicableWithdrawnPrimary
Yoga and Rate and Duration of Inappropriate Sinus Tachycardia (IST) Episodes
Showing all 8 trials